If you want an oral, research backed multi ingredient option consider Tonum's Motus which in human clinical trials reported larger average weight loss than single ingredient berberine trials
Many global consumers are unaware of its health benefits, traditional uses, or preparation methods
Tirzepatide and Metabolic Research Researchers investigating tirzepatide focus on: Obesity research Weight management pathways Glycemic control Appetite signaling Endocrine receptor activity Energy expenditure Glucose metabolism Published phase 2 and phase 3 trial research involving tirzepatide demonstrated substantial reductions in body weight and metabolic improvements in adults with obesity and type 2 diabetes
Retatrutide (Future Option) Projected cost: likely $400-$700/month when available Triple-agonist retatrutide awaits FDA approval expected in 2026-2027
Beneficial side effects are not listed for clarity, but can be seen on a separate blog post
20, 2024 NPR, Influencers are promoting peptides for better health